OR Royalties Inc. (NYSE:OR) Receives Consensus Recommendation of “Moderate Buy” from Analysts

OR Royalties Inc. (NYSE:OR) has earned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $38.25.

OR has been the topic of a number of research analyst reports. Raymond James Financial raised shares of OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 price target on the stock in a report on Thursday, November 6th. Wall Street Zen upgraded OR Royalties from a “buy” rating to a “strong-buy” rating in a research report on Monday, January 19th. Scotiabank raised their price target on OR Royalties from $41.00 to $51.00 and gave the company a “sector perform” rating in a research report on Monday, January 26th. CIBC restated an “outperform” rating on shares of OR Royalties in a report on Wednesday. Finally, Canaccord Genuity Group upgraded OR Royalties from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 22nd.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in OR. Linden Thomas Advisory Services LLC grew its stake in OR Royalties by 4.1% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 6,254 shares of the basic materials company’s stock valued at $221,000 after purchasing an additional 249 shares in the last quarter. Allworth Financial LP grew its position in shares of OR Royalties by 20.0% during the 4th quarter. Allworth Financial LP now owns 2,305 shares of the basic materials company’s stock worth $82,000 after purchasing an additional 384 shares in the last quarter. Cetera Investment Advisers lifted its position in shares of OR Royalties by 3.5% during the 2nd quarter. Cetera Investment Advisers now owns 13,147 shares of the basic materials company’s stock valued at $337,000 after acquiring an additional 440 shares during the period. Vident Advisory LLC raised its position in shares of OR Royalties by 2.0% in the 2nd quarter. Vident Advisory LLC now owns 42,349 shares of the basic materials company’s stock valued at $1,089,000 after buying an additional 820 shares in the last quarter. Finally, Assetmark Inc. acquired a new position in OR Royalties during the fourth quarter worth about $36,000. 68.52% of the stock is currently owned by institutional investors.

OR Royalties Trading Down 5.8%

NYSE OR opened at $38.70 on Friday. The firm has a market capitalization of $7.24 billion, a P/E ratio of 48.99 and a beta of 0.76. The business has a fifty day simple moving average of $38.30 and a 200 day simple moving average of $35.12. OR Royalties has a 12 month low of $17.55 and a 12 month high of $47.75.

OR Royalties (NYSE:OR) last posted its quarterly earnings data on Wednesday, November 5th. The basic materials company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.03. OR Royalties had a net margin of 60.72% and a return on equity of 10.67%. The firm had revenue of $71.63 million for the quarter, compared to the consensus estimate of $53.85 million. As a group, sell-side analysts predict that OR Royalties will post 0.62 EPS for the current fiscal year.

OR Royalties Company Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.